Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

The First Component of Complement in Serum: Evidence for a Hitherto Unrecognized Factor in C1 Necessary for Internal Activation

M. Loos, T. Borsos and H. J. Rapp
J Immunol January 1, 1973, 110 (1) 205-212;
M. Loos
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. Borsos
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. J. Rapp
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

The lack of direct proportionality between the number of SAC14 formed and the concentration of serum C1 was ascribed to the dissociation of C1 molecules into their subcomponents. We have obtained evidence, however, that this non-linear relationship is due to the dissociation from the C1 molecule of a hitherto unrecognized factor necessary for the activation of bound C1. Determination of the hemolytic activity of EAC14 before and after treatment with trypsin demonstrated that EAC14 contained two populations of SAC14, one in which C1 was activable by itself and by trypsin and another in which C1 was activable by trypsin but not by itself. A factor necessary for activation of C1, missing in non-self-activable C1, was designated “X” and the C1 molecules lacking this factor were designated (C1 - X). The finding that the apparent C1 content of whole serum was dependent on EAC4 concentration indicated that the activating factor “X” was bound independently from C1 and (C1 - X).

Footnotes

  • ↵1 Guest worker in the Biology Branch, National Cancer Institute. Supported by the Deutsche Forschungsgemeinschaft (Lo 188/1).

  • Received August 8, 1972.
  • Copyright, 1972, by The Williams & Wilkins Company
  • Copyright © 1973 by The American Association of Immunologists, Inc.

Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$37.50

Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.

Log in using your username and password

Forgot your user name or password?
PreviousNext
Back to top

In this issue

The Journal of Immunology
Vol. 110, Issue 1
1 Jan 1973
  • Table of Contents
  • Table of Contents (PDF)
  • Advertising (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The First Component of Complement in Serum: Evidence for a Hitherto Unrecognized Factor in C1 Necessary for Internal Activation
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The First Component of Complement in Serum: Evidence for a Hitherto Unrecognized Factor in C1 Necessary for Internal Activation
M. Loos, T. Borsos, H. J. Rapp
The Journal of Immunology January 1, 1973, 110 (1) 205-212;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The First Component of Complement in Serum: Evidence for a Hitherto Unrecognized Factor in C1 Necessary for Internal Activation
M. Loos, T. Borsos, H. J. Rapp
The Journal of Immunology January 1, 1973, 110 (1) 205-212;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Generation of Biologic Activity from the Purified α-Chain of C5
  • Synthesis of a Lipopolysaccharide Designed to Conjugate Haptens and Proteins to Erythrocytes for Use as Target Cells in Passive Hemagglutination and Hemolytic Assays
  • Cross-Reactivity of Rat, Mouse, and Human IgD
Show more Immunochemistry

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606